January 24, 2017
The Pharmaceutical Affairs and Food Sanitation Council’s Second Committee on Drugs will discuss on February 3 whether to recommend approval for Sanofi’s VEGF inhibitor aflibercept beta for the treatment of colorectal cancer. The detailed indication to be discussed for aflibercept...read more